FULL PAPERS
Panpan Qu et al.
N-[4-(Trifluoromethoxy)benzyl]-4-methylbenzenesulfona-
mide (3am): mp 85–868C; H NMR (500 MHz, CDCl3): d=
7.73 (d, J=8.3 Hz, 2H, ArH), 7.30 (d, J=8.1 Hz, 2H, ArH),
7.23 (d, J=8.4 Hz, 2H, ArH), 7.11 (d, J=8.3 Hz, 2H, ArH),
4.71 (br s, 1H, NH), 4.15 (d, J=6.3 Hz, 2H, CH2NH), 2.43
(s, 3H, CH3); 13C NMR (125 MHz, CDCl3): d=148.7, 143.7,
CH3), 1.68–1.66 (m, 5H, 2CH2, CH), 1.41–1.38 (m, 1H,
CH), 1.21–1.06 (m, 3H, CH2, CH), 0,88–0.81 (m, 2H, CH2);
13C NMR (125 MHz, CDCl3): d=143.2, 137.1, 129.6, 127.0,
49.3, 37.7, 30.5, 26.2, 25.6, 21.5.
1
N-Benzyl-2-methylbenzenesulfonamide (3ba):[10j] mp 57–
588C; 1H NMR (500 MHz, CDCl3): d=7.99 (d, J=7.6 Hz,
1H, ArH), 7.46 (t, J=7.3 Hz, 1H, ArH), 7.34–7.24 (m, 5H,
ArH), 7.16 (d, J=6.4 Hz, 2H, ArH), 4.76 (br s, 1H, NH),
4.11 (d, J=5.9 Hz, 2H, CH2NH), 2.62 (s, 3H, CH3);
13C NMR (125 MHz, CDCl3): d=137.7, 137.0, 136.2, 132.8,
132.5, 129.6, 128.6, 127.8, 126.1, 47.1, 20.2; HR-MS-EI
(70 eV): m/z=284.0722, calcd. for C12H19NO2SNa [M+
Na]+: 264.1034.
136.9, 135.2, 129.7, 129.3, 127.1, 123.4, 121.1, 120.4 (q, JCÀF
=
255.8 Hz), 46.4, 21.5; HR-MS-EI (70 eV): m/z=368.0538,
calcd, for C15H14NO3F3SNa [M+Na]+: 368.0544.
4-Methyl-N-(naphthalen-2-ylmethyl)benzenesulfonamide
(3an):[10a] mp 131–1328C; 1H NMR (500 MHz,CDCl3): d=
7.80–7.71 (m, 5H, ArH), 7.60 (s, 1H, ArH), 7.47–7.46 (m,
2H, ArH), 7.31–7.27 (m, 3H, ArH), 4.78 (br s, 1H, NH),
4.29 (d, J=5.9 Hz, 2H, CH2NH), 2.41(d, J=3.7 Hz, 3H,
CH3); 13C NMR (125 MHz, CDCl3): d=143.5, 136.9, 133.6,
133.2, 132.9, 129.7, 128.5, 127.7. 127.6, 127.2, 126.7, 126.3,
126.1, 125.6, 47.4, 21.5.
4-Methyl-N-(thiophen-2-ylmethyl)benzenesulfonamide
(3ao):[10b] mp 111–1128C; 1H NMR (500 MHz,CDCl3): d=
7.76 (d, J=8.0 Hz, 2H, ArH), 7.31 (d, J=7.9 Hz, 2H, ArH),
7.20 (d, J=5.1 Hz, 1H, ArH), 6.89 (t, J=4.2 Hz, 1H, ArH),
6.86 (s, 1H, ArH), 4.67 (br s, 1H, NH), 4.33 (s, 2H,
CH2NH), 2.44 (s, 3H, CH3); 13C NMR (125 MHz, CDCl3):
d=143.6, 138.9, 136.7, 129.7, 127.2, 126.8, 126.5, 125.8, 42.6,
21.5.
N-Benzyl-4-methoxybenzenesulfonamide (3ca):[7j] mp
106–1078C; 1H NMR (500 MHz, CDCl3): d=7.80 (d, J=
8.8 Hz, 2H, ArH), 7.30–7.24 (m, 3H, ArH), 7.19 (d, J=
7.9 Hz, 2H, ArH), 6.99–6.95 (m, 2H, ArH), 4.68 (br s, 1H,
NH), 4.11 (d, J=6.2 Hz, 2H, CH2NH), 3.88 (s, 3H, OCH3);
13C NMR (125 MHz, CDCl3): d=162.9, 136.3, 131.4, 129.2,
128.6, 127.81, 127.78, 114.2, 55.6, 47.2.
N-Benzyl-4-fluorobenzenesulfonamide (3da):[10b] mp 96–
1
978C; H NMR (500 MHz, CDCl3): d=7.86 (dd, J=8.8 Hz
and 4.7 Hz, 2H, ArH), 7.30–7.25 (m, 3H, ArH), 7.20–7.14
(m, 4H, ArH), 4.82 (br s, 1H, NH), 4.15 (s, 2H, CH2NH);
13C NMR (125 MHz, CDCl3): d=165.0 (d, JC,F =253.7 Hz),
136.02, 135.97, 129.8 (d, JC,F =9.9 Hz), 128.7, 127.9, 127.8,
116.2 (d, JC,F =22.2 Hz), 47.2.
N-Ferrocenemethyl-4-methylbenzenesulfonamide (3ap):
1
mp 121–1228C; H NMR (500 MHz, CDCl3) d 7.77 (d, J=
8.0 Hz, 2H, ArH), 7.33 (d, J=8.0 Hz, 2H, ArH), 4.44 (br s,
1H, NH), 4.20–4.08 (m, 9H, ferrocene H), 3.80(d, J=8.0 Hz,
2H, CH2NH), 2.45 (s, 3H, CH3); 13C NMR (125 MHz,
CDCl3): d=143.4, 136.9, 129.7, 127.1, 83.6, 68.6, 68.3, 67.9,
42.5, 21.5; HR-MS-EI (70 eV): m/z=392.0389, calcd. for
C18H19NO2SFeNa [M+Na]+: 392.0384.
N-Benzyl-2-chlorobenzenesulfonamide (3ea):[10b] mp 88–
908C; 1H NMR (500 MHz,CDCl3): d=8.08 (d, J=7.4 Hz,
1H, ArH), 7.51–7.46 (m, 2H, ArH), 7.41–7.38 (m, 1H,
ArH), 7.28–7.21 (m, 3H, ArH), 7.20–7.16 (m, 2H, ArH),
5.29 (br s, 1H, NH), 4.12 (s, 2H, CH2NH); 13C NMR
(125 MHz, CDCl3): d=137.2, 135.7, 133.7, 131.5, 131.33,
131.28, 128.6, 128.0, 127.9, 127.2, 47.5.
N-Butyl-4-methylbenzenesulfonamide (3aq):[7j] mp 38–
398C; 1H NMR (500 MHz, CDCl3): d=7.75 (d, J=8.0 Hz,
2H, ArH), 7.31 (d, J=8.0 Hz, 2H, ArH), 4.54 (br s, 1H,
NH), 2.93 (quart, J=6.7 Hz, 2H, CH2N), 2.43 (s, 3H, CH3),
1.44 (quint, J=7.3 Hz, 2H, CH2), 1.29 (sext, J=7.5 Hz, 2H,
CH2), 0.85 (t, J=7.3 Hz, 3H, CH3); 13C NMR (125 MHz,
CDCl3): d=143.2, 136.9, 129.6, 127.0, 42.9, 31.5, 21.4, 19.6,
13.5.
N-Benzyl-3-chlorobenzenesulfonamide (3fa): mp 79–
1
808C; H NMR (500 MHz, CDCl3): d=7.83 (s, 1H, ArH),
7.74 (d, J=7.9 Hz, 1H, ArH), 7.54 (d, J=7.9 Hz, 1H, ArH),
7.44 (t, J=7.9 Hz, 1H, ArH), 7.31–7.26 (m, 3H, ArH), 7.20
(d, J=6.7 Hz, 2H, ArH), 4.76 (br s, 1H, NH), 4.18 (d, J=
6.1 Hz, 2H, CH2NH); 13C NMR (125 MHz, CDCl3): d=
141.7, 135.8, 135.2, 132.8, 130.4, 128.7, 128.1, 127.9, 127.2,
125.1, 47.3; HR-MS-EI (70 eV): m/z=304.0173, calcd. for
C13H12NO2SClNa [M+Na]+: 304.0175.
N-Hexyl-4-methylbenzenesulfonamide (3ar):[10b] mp 61–
628C; 1H NMR (500 MHz, CDCl3): d=7.74 (d, J=8.3 Hz,
2H, ArH), 7.31 (d, J=7.9 Hz, 2H, ArH), 4.33 (br s, 1H,
NH), 2.93 (quart, J=6.8 Hz, 2H, CH2N), 2.43 (s, 3H, CH3),
1.44 (quint, J=7.1 Hz, 2H, CH2), 1.28–1.16 (m, 6H, 3xCH2),
0.85 (t, J=6.9 Hz, 3H, CH3); 13C NMR (125 MHz, CDCl3):
d=143.3, 137.0, 129.6, 127.1, 43.2, 31.2, 29.5, 26.1, 22.4, 21.5,
13.9.
N-Benzyl-4-bromobenzenesulfonamide (3ga):[10b] mp 119–
1208C; 1H NMR (500 MHz,CDCl3): d=7.71 (d, J=6.6 Hz,
2H, ArH), 7.64 (d, J=6.7 Hz, 2H, ArH), 7.28 (s, 3H, ArH),
7.19 (s, 2H, ArH), 4.76 (br s, 1H, NH), 4.16 (s, 2H,
CH2NH); 13C NMR (125 MHz, CDCl3): d=139.0, 135.9,
132.3, 128.7, 128.6, 128.0, 127.8, 127.6, 47.2.
N-Isopentyl-4-methylbenzenesulfonamide (3as):[29] oil;
1H NMR (500 MHz, CDCl3): d=7.75 (d, J=8.3 Hz, 2H,
ArH), 7.31(d, J=8.3 Hz, 2H, ArH), 4.47 (br s, 1H, NH),
2.94 (quart, J=7.0 Hz, 2H, NCH2), 2.43 (s, 3H, CH3), 1.58
(heptet, J=6.8 Hz, 1H, CH), 1.33 (quart, J=7.2 Hz, 2H,
CH2), 0.83 (d, J=6.7 Hz, 6H, 2CH3); 13C NMR (125 MHz,
CDCl3): d=143.3, 136.9, 129.7, 127.1, 41.4, 38.3, 25.4, 22.2,
21.5; HR-MS-EI (70 eV): m/z=264.1040, calcd. for
C12H19NO2SNa [M+Na]+ 264.1034.
N-Benzyl-4-nitrobenzenesulfonamide (3ha):[13b] mp 124–
1
1258C; H NMR (500 MHz, CDCl3): d=8.30 (d, J=8.7 Hz,
2H, ArH), 7.99 (d, J=8.6 Hz, 2H, ArH), 7.28–7.25 (m, 3H,
ArH), 7.18–7.15 (m, 2H, ArH), 4.99 (br s, 1H, NH), 4.23 (d,
J=6.0 Hz, 2H, CH2NH); 13C NMR (125 MHz, CDCl3): d=
149.9, 146.0, 135.5, 128.8, 128.3, 128.2, 127.9, 124.3, 47.3.
N-Benzyl-4-(trifluoromethyl)benzenesulfonamide (3ia):[30]
1
mp 114–1158C; H NMR (500 MHz, CDCl3): d=7.95 (d, J=
7.9 Hz, 2H, ArH), 7.74 (d, J=8.0 Hz, 2H, ArH), 7.27–7.17
(m, 5H, ArH), 7.18 (d, J=7.2 Hz, 2H, ArH), 4.91 (br s, 1H,
NH), 4.20 (d, J=4.8 Hz, 2H, CH2NH); 13C NMR (125 MHz,
CDCl3): d=143.7, 135.6, 134.3 (q, JC,F =33.0 Hz), 128.8,
128.1, 127.9, 127.6, 126.2, 123.2 (q, JC,F =271.4 Hz), 47.3;
N-(Cyclohexylmethyl)-4-methylbenzenesulfonamide
1
(3at):[10a] mp 80–818C; H NMR (500 MHz, CDCl3): d=7.74
(d, J=8.1 Hz, 2H, ArH), 7.31 (d, J=7.9 Hz, 2H, ArH), 4.40
(br s, 1H, NH), 2.76 (t, J=6.6 Hz, 2H, CH2N), 2.43 (s, 3H,
456
ꢁ 2014 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Adv. Synth. Catal. 2014, 356, 447 – 459